Source:http://linkedlifedata.com/resource/pubmed/id/17102647
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
8
|
pubmed:dateCreated |
2006-11-14
|
pubmed:abstractText |
Plasma D-dimer levels, the primary degradation product of cross-linked fibrin, are elevated in acute coronary syndrome (ACS). However, the role of D-dimer in patients presenting to the Emergency Department with ACS and normal cardiac enzymes is unknown. We conducted a prospective, observational study in the Emergency Department of a major tertiary university-affiliated center. The study included 124 patients presented to the Emergency Department with ACS and normal cardiac enzymes. Blood samples were collected and assayed for D-dimer levels with the enzyme-linked immunosorbent assay (ELISA) test. The D-dimer values were correlated with the clinical, laboratory and electrocardiographic findings on admission, as well as with the catheterization findings and with hospital length of stay. ELISA D-dimer levels positively correlated with sex, hypertension and smoking (r = -0.27, P = 0.002; r = 0.33, P = 0.0002; and r = -0.24, P = 0.007, respectively). Significant correlation was also observed between ELISA D-dimer and cardiac medications including beta-blocker (r = 0.22, P = 0.01), aspirin (r = 0.18, P = 0.04), nitrate (r = 0.20, P = 0.002), acute phase reactants fibrinogen (r = 0.45, P = 0.0001) and C-reactive protein (r = 0.29, P = 0.004), ischemic electrocardiographic changes (r = 0.21, P = 0.02) and length of stay (r = 0.29, P = 0.001). The catheterization findings were also correlated with the ELISA D-dimer levels (r = 0.31, P = 0.02). The ELISA D-dimer test may add important clinical data concerning patients with ACS and normal cardiac enzymes.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0957-5235
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
17
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
621-4
|
pubmed:meshHeading |
pubmed-meshheading:17102647-Aged,
pubmed-meshheading:17102647-Biological Markers,
pubmed-meshheading:17102647-Electrocardiography,
pubmed-meshheading:17102647-Emergency Medical Services,
pubmed-meshheading:17102647-Enzyme-Linked Immunosorbent Assay,
pubmed-meshheading:17102647-Enzymes,
pubmed-meshheading:17102647-Female,
pubmed-meshheading:17102647-Fibrin Fibrinogen Degradation Products,
pubmed-meshheading:17102647-Heart Catheterization,
pubmed-meshheading:17102647-Humans,
pubmed-meshheading:17102647-Ischemia,
pubmed-meshheading:17102647-Male,
pubmed-meshheading:17102647-Middle Aged,
pubmed-meshheading:17102647-Myocardial Infarction,
pubmed-meshheading:17102647-Prospective Studies
|
pubmed:year |
2006
|
pubmed:articleTitle |
The role of enzyme-linked immunosorbent assay D-dimer in patients with acute coronary syndrome presenting with normal cardiac enzymes.
|
pubmed:affiliation |
Internal Medicine Department, Shaare-Zedek Medical Center, Jerusalem, Israel.
|
pubmed:publicationType |
Journal Article,
Evaluation Studies
|